Bedford Laboratories First to Manufacture FDA Approved Indomethacin for Injection USP
Epigenomics AG: Blood Test for Colorectal Cancer Now Available Nationwide in Germany and Switzerland
To keep up to date with news from this category use our
Introducing NEUTROGENA CLINICAL(TM) with ION2COMPLEX(TM) Technology
Los Angeles, CA (March 11 2010) -- After years of research and ten new technology patents, Neutrogena
IntelGenx Granted Bupropion Patent
SAINT LAURENT, QUEBEC, Mar 10, 2010 -- IntelGenx Corp. (IGX)(US:IGXT) ("IntelGenx") today announced that the U.S. Patent and Trademark Office ("USPTO") issued patent number 7,674,479 on March 9, 2010 for a key patent...
Lorus Therapeutics Announces Allowance of a Patent on its Small Molecule Program
TORONTO, CANADA, March 10, 2010 - Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products and technologies for the...
Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
Miami Beach, FL (March 5th 2010) -- Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to...
Court Issues Permanent Injunction Enjoining OMI from Infringing a Retractable Technologies, Inc. Syringe Patent
LITTLE ELM, Texas--March 5, 2010--Retractable Technologies, Inc. ("Retractable") (AMEX: RVP), a leading maker of safety needle devices, announced that a final judgment and permanent injunction were entered March 4, 2010...
Issuance of Xen2174 Patent in Japan - 4 March 2010
Brisbane, Australia. 04 March 2010: Xenome Limited ("Xenome") today announced that the Japanese Patent Office has issued patent number 4447783, entitled "Novel Peptides". This patent relates to a novel class of...
Repligen Announces Acquisition of Chromatography Technology Platform "Plug and Play" Products Create Broad Opportunity in Biopharmaceutical Manufacturing
WALTHAM, MA - March 3, 2010 - Repligen Corporation (NASDAQ: RGEN) announced today that it has acquired the assets of BioFlash Partners, LLC, (BioFlash) including a technology platform for the production of pre-packed,...
KEY BONE REPAIR PATENT GRANTED IN THE UNITED STATES
Melbourne, Australia; 3 March 2010: Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that the United States Patent and Trademark Office (USPTO) has granted a key patent that...
PAREXEL EXPERTS TO PRESENT LEADING INSIGHTS REGARDING KEY INDUSTRY TOPICS AT 22ND ANNUAL DIA EUROMEETING
Boston, MA, March 2, 2010 -- Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information...
YM sees nimotuzumab license unaffected by civil claim against licensor
MISSISSAUGA, ON, March 2, 2010 -- YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announces that it filed a Form 6K describing that certain US patents for nimotuzumab licensed to YM's majority-owned Canadian subsidiary ,...
Merrion Pharmaceuticals is issued a key United States patent
DUBLIN, IRELAND, 2nd March 2010 - Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical company, today announced the issuance of United States Patent No. 7,658,938, "Solid Oral Dosage Form...
PURE Bioscience Announces Nationwide Launch of IV-7 Ultimate Germ Defense(TM) by Richmont Sciences
SAN DIEGO March 1, 2010 - PURE Bioscience (NASDAQ: PURE) today announced the nationwide launch of IV-7 Ultimate Germ Defense(TM) (IV-7), an advanced, broad-spectrum disinfectant with PURE's patented silver dihydrogen...
BioSante Pharmaceuticals Receives Two New Patents for Manufacture of Proteins, Including Antibodies
LINCOLNSHIRE, Illinois (March 1, 2010) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the receipt of two US patents directed to its 2A/Furin technology for expressing proteins. The first issued US...
ENZO BIOCHEM ANNOUNCES FAVORABLE JUDGMENT BY U.S. PATENT OFFICE IN AN INTERFERENCE AGAINST BAYER HEALTHCARE FOR A UNIVERSAL DIAGNOSTIC DETECTION SYSTEM
NEW YORK, NY, March 1, 2010 - Enzo Biochem, Inc., (NYSE:ENZ) today announced that the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office has entered judgment in favor of Enzo and...
Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
ROCKVILLE, Md., Feb 25, 2010-- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere,...
Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
HOPKINTON, Mass., Feb 24, 2010 -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, and its wholly owned subsidiary Xenogen Corporation,...
Epigenomics AG: Blood Test for Colorectal Cancer Now Available Nationwide in Germany and Switzerland
Berlin, Germany, and Seattle, WA, U.S.A., February 23, 2010 - Only four months after launch, Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, today reported that its blood based...
Varian Medical Systems Awarded a Patent for Improving X-Ray Shielding
SALT LAKE CITY, Feb. 22, 2010-- Varian Medical Systems, Inc. (NYSE: VAR), a premier supplier of X-ray tubes and flat panel digital image detectors, announced it has been awarded a patent for improved shielding in X-ray...
ETHICON ENDO-SURGERY ANNOUNCES AGREEMENT WITH HOLOGIC, INC. TO RESOLVE PATENT DISPUTES
CINCINNATI- February 19, 2009 - Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, announced today that it has reached an agreement with Hologic, Inc., and Hologic subsidiary Suros Surgical Systems, Inc., settling...
Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
Cincinnati, OH (February 19, 2010) - Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, announced today that it has reached an agreement with Hologic, Inc., and Hologic subsidiary Suros Surgical Systems, Inc.,...
Positron Receives US Patent for Tech-Assist
INDIANAPOLIS--February 18, 2010--Positron Corporation (OTCBB:POSC - News) a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the U.S. Patent and Trademark office has allowed for...
Cellectis and Genoway close their disagreement
Paris, February 18, 2010 - Cellectis (Alternext: ALCLS) and Genoway indicate that the sublicense agreement dated September 7, 2001, relating to the patents and patent applications belonging to the pool WO90/11354 has...
Health Discovery Corporation selected as "Best & Brightest" Small Cap Company by MDB Capital Group and Expands Patent Portfolio
SAVANNAH, Ga. - February 18, 2010 - Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has been listed among the "Best & Brightest" qualifying small cap companies by MDB Capital Group LLC.
Echo Therapeutics Announces Significant Product Development Milestone: The Completion of Next Generation Electronic Components for its Revolutionary, Patented Symphony(TM) tCGM System
Franklin, MA - February 18, 2010 -- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM)...
UCLA School of Nursing Selects QuantRx PadKit
DOYLESTOWN, PA - February 16, 2010 - QuantRx
GeneNews announces issuance of second foundational U.S. patent for core Sentinel Principle
TORONTO, CANADA (February 16, 2010): GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that...
Genetic Technologies moves to assert its intellectual property rights and files patent infringement suit in USA
February 16, 2010 - Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to advise that it has filed a patent infringement suit in respect of its non-coding DNA technologies against nine parties in the US...
EKR Therapeutics Receives Two Additional Patents for Ready-to-Use Cardene
Bedminster, N.J., February 16, 2010 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has...
Eurand Issued U.S. Patent for ZENPEP(R) (pancrelipase) Delayed-Release Capsules
PHILADELPHIA, PA, Feb 16, 2010 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today the grant of U.S. Patent No. 7,658,918, titled "STABLE DIGESTIVE ENZYME COMPOSITIONS," by the...
U.S. District Court for the Eastern District of Texas finds Arthrex guilty of infringing Smith & Nephew Endoscopy patent
ANDOVER, Mass., FEBRUARY 16, 2010 - Smith & Nephew, Inc., Endoscopy Division, a subsidiary of Smith & Nephew plc (NYSE:SNN) (London Stock Exchange: SN) announced today that the United States District Court for the...
BioSante Pharmaceuticals Rated Among Top 15 Companies on The Biotechnology Patent Scorecard(TM) as published in The Wall Street Journal
LINCOLNSHIRE, Illinois (February 16, 2010) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), has been ranked 15th on The Patent Board's list of the top 67 biotechnology companies as determined by an assessment of the...
Bedford Laboratories(TM) First to Manufacture Generic Indomethacin for Injection USP
BEDFORD, OH - February 16, 2010 - Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to...
Bedford Laboratories First to Manufacture FDA Approved Indomethacin for Injection USP
BEDFORD, OH - February 16, 2010 - Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to...
Health Discovery Corporation Introducing The World's First Mobile Phone App for Melanoma and Other Skin Cancers Using SVM-based Image Analysis Techniques
SAVANNAH, Ga.--February 16, 2010--Health Discovery Corporation (OTCBB: HDVY) announced today that the Company is nearing completion in the development of a melanoma/skin cancer mobile phone application (App) which will...
Positive in vivo data show that Creative Antibiotics drug substance can prevent chlamydia infection
February 16, 2010 - The Ume
XYLOS EXPANDS PATENT POSITION FOR ITS UNIQUE, RESORBABLE BIOMATERIAL
Langhorne, PA - February 16, 2010 . . . . Xylos Corporation ("Xylos" or the "Company"), a leader in biocellulose technology for medical applications, announced that it received a new Notice of Allowance from the U.S....
From Oceans to Crops, and From Crops to IPOm Ac
February 15, 2010. Bangalore Avesthagen has always been in the forefront of innovative scientific thinking and has developed a formidable portfolio of patents in all the four areas it operates in viz. bioAgriculture,...
DIAGNOCURE ANNOUNCES OPTIMIZATION OF ENTREPRISE STRUCTURE
QUEBEC CITY, February 15, 2010 DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing highvalue cancer diagnostic tests and delivering laboratory services, today announced changes to its enterprise...
USPTO GRANTS FORMATECH NOVEL DRUG FORMULATION PATENT
Andover, MA - February 11, 2010 - Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled "Methods of Enhancing Solubility of Agents" which covers novel formulation methods to enhance the...
German Appeals Court Says CoreValve Devices From Medtronic Do Not Infringe Edwards Lifesciences' Andersen Patent
MINNEAPOLIS - Feb. 11, 2010 - Medtronic, Inc. (NYSE: MDT), announced today that an appeals court in Germany has found that the CoreValve
Skinvisible's Safe4Hours Promotion in Walgreens Expands
Las Vegas, NV- February 11, 2010 - Skinvisible, Inc. (SKVI:OTCBB) announces JD Nelson and Associates LLC, its license holder of the newly launched Safe4Hours
BioCurex Announces Commercialization of OncoPet RECAF(TM), the First Blood Test for Cancer Detection in Companion Animals
RICHMOND, British Columbia, Feb. 11, 2010 -- BioCurex Inc. (OTCBB:BOCX - News), a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, today announced that it has...
ABLYNX WINS PATENT OPPOSITION CASE AGAINST DOMANTIS (GSK)
GHENT, Belgium, 11 February 2010 - Ablynx [Euronext Brussels: ABLX] today announced that it has been successful in the opposition that it had filed in 2007 against the European Patent 1 517 921, which was granted in...
Athersys Receives U.S. Patent Covering Adult Stem Cell Composition & Production
CLEVELAND, Feb 10, 2010 -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their isolation and expansion, and related...
AVANIR Pharmaceuticals Announces Issuance of New U.S. Zenvia Patent
ALISO VIEJO, Calif., February 10, 2010 - AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug...
Company Announcement no. 5 - 2009/10 - Postive development in revenue and results continues
February 09, 2010--With growth in revenue of 7% when measured in local currencies in Q1 2009/10, Ambu is winning market share and developments remain positive for the company. The operating profit, EBIT, for Q1 was DKK...
Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
Halifax, Nova Scotia; February 8, 2010 - Immunovaccine Inc. (TSX-V:IMV) announced today that it has been invited to present at the Canada - U.S. Partners in Biomedical Defense II Conference in Washington, D.C. on...
Volcano Corporation Announces Litigation Status
SAN DIEGO, Feb 05, 2010 -- Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County...
Cambrios Announces Issuance of an Important Inlicensed Patent Claiming Methods of Nanostructure Formation and Shape Selection
Sunnyvale, CA -- February 4, 2010 -- Cambrios Technologies Corporation announced today that an important patent has issued covering commercially relevant methods of manufacturing metal nanostructures. U.S. Patent number...
Company Receives Second Patent on Rapid Thermocycling Methodology for Molecular Diagnostics
REDMOND, Wash., USA (February 2, 2010) - BusinessWire - Micronics, Inc. today announced that it has been issued a second letters patent from the United States Patent and Trademark Office (USPTO) for an integrated heat...
Entelos Granted Patent for Innovative Diagnostic Capability in Obesity, Diabetes
Foster City, CA, February 2, 2010 - Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled...
Boston Scientific Settles Longstanding Patent Disputes With J&J
NATICK, Mass., Feb. 1 -- Boston Scientific Corporation (NYSE: BSX) today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang...
ZIOPHARM Receives Important Palifosfamide U.S. Patent Allowance
NEW YORK, Jan 26, 2010 -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts...
Creative Antibiotics research cooperation may signify a breakthrough for drugs used to treat sexually transmitted diseases
January 26, 2010 - The Ume
Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21
CARLSBAD, Calif. & CAMBRIDGE, Mass., Jan 25, 2010 -- Regulus Therapeutics Inc., Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that the United States Patent...
VINYTHAI PREPARES CONSTRUCTION OF ITS EPICHLOROHYDRIN PLANT IN THAILAND
January 7, 2010--Solvay announces that it has recently closed the sale to its Thai affiliate Vinythai of all shares in Solvay Biochemical Thailand for a total value of EUR 7 million. This subsidiary of Solvay is now...
Pfizer and Strides Arcolab to Collaborate on Generic Products
NEW YORK--January 05, 2010-- Pfizer (NYSE: PFE) and Strides Arcolab (BSE: 532531, NSE: STAR) today announced a new collaboration, wherein Pfizer will commercialize off-patent sterile injectable and oral products in the...
EndoGastric Solutions Announces Key Patent Issued
Redwood City, CA (December 31, 2009) - EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a...
Isis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics
CARLSBAD, Calif. & CAMBRIDGE, Mass.--December 15, 2009--Isis Pharmaceuticals, Inc. (Nasdaq: ISIS - News) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News) announced today that the United States Patent and...
Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health
Halifax, Nova Scotia and New York, NY; November 23, 2009 - Immunovaccine Inc. (TSX-V: IMV). ), a vaccine development company, today announced the signing of an exclusive, worldwide license agreement with Pfizer Animal...
SpermSep Australian Patent Granted
SYDNEY, AUSTRALIA - 9th November 2009 - NuSep (ASX: NSP) is pleased to announce that the Australian patent for the SpermSep has now been granted.
Regulus Announces U.S. Allowance of Fundamental microRNA Therapeutics Patent Application
CARLSBAD, Calif. & CAMBRIDGE, Mass.--Oct. 28, 2009-- Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the United...
First Set in a Series of siRNA Sequence Patent Applications Licensed to RXi Pharmaceuticals are Allowed in the United States
WORCESTER, Mass.----Oct. 1, 2009-- RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi),...
NuGEN enters the Whole Genome Amplification arena with the new Ovation
San Carlos, Calif.--September 30, 2009--NuGEN Technologies, Inc., a pace-setter in nucleic acid sample preparation, announces its entrance into the DNA market today with the Ovation WGA System, a linear, remarkably...
Agion
Wakefield, MA, September 30, 2009 - Frost & Sullivan has named Agion Technologies the recipient of its 2009 Customer Value Leadership Award, in recognition of the company's provision of innovative and customized...
Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
CLEVELAND, September 30, 2009 -- Ganeden Biotech Inc., makers of the patented probiotic strain GanedenBC30(R) (Bacillus coagulans GBI-30, 6086), today announced two grants for early investigators. Grants focus on...
Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
NATICK, Mass., Sept. 29 -- Boston Scientific Corporation (NYSE: BSX) today announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the Palmaz-NIR suit. All the disputes involved...
Cordis Corporation Announces Agreement with Boston Scientific to Settle Selected Stent Litigation Cases
Bridgewater, NJ -- September 29, 2009 - Cordis Corporation ("Cordis") announced today that it has reached an agreement with Boston Scientific ("Boston") resolving its Palmaz infringement suit relating to Boston's NIR...
Buckingham Group and ViaLogy Finalize Three Reservoir Prospects Additional Customer Contracts Signed Major DOD Contract Win with Partner SAIC
Pasadena, September 29, 2009 - Vialogy (LSE: VIY) ViaLogy announces that it has finalized Project Agreements for three onshore oil prospects under a multi-site services contract with The Buckingham Group of San Angelo,...
Actavis launches Topiramate on day one in four European markets
September 29, 2009--Actavis today announced the launch of the antiepileptic drug Topiramate in the UK, Germany, France and Switzerland. The product was launched on day one as the originator's patent expired on 25...
PolyMedix Receives U.S. Patent Protection for Licensed Computational Methods to Design Antimicrobial Polymers
Radnor, PA (September 28, 2009) - PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on...
Regulus, Alnylam, and Isis Announce First microRNA Patent Grant in Japan from Tuschl III Patent Series
CARLSBAD, Calif. & CAMBRIDGE, Mass.--Sep. 17, 2009-- Regulus Therapeutics Inc., Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the Japan Patent Office...
U.S. Patent and Trademark Office Issues a Notice of Allowance in OSI Pharmaceuticals' Reissue Application on Tarceva(R) Composition of Matter Patent
MELVILLE, N.Y., Sep 17, 2009 -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent...
Medtronic and W.L. Gore & Associates Settle Patent Dispute
MINNEAPOLIS - September 16, 2009 - Medtronic, Inc. (NYSE: MDT) today announced that it has settled a patent lawsuit it initiated against W.L. Gore & Associates. Medtronic sued W.L. Gore in 2006 for patent infringement...
Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
CAMBRIDGE, Mass. and CARLSBAD, Calif., Sept. 10, 2009 -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office...
Martek Announces Settlement of Patent Dispute with Capsugel France
COLUMBIA, Md., September 10, 2009 -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The...
Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
TUSTIN, Calif., Sept 08, 2009 -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported completion of patient enrollment in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel...
Federal Circuit Rules in Martek's Favor in Appeal of Patent Infringement Case
COLUMBIA, Md., September 08, 2009 -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that a panel of judges on the United States Court of Appeals for the Federal Circuit has ruled in Martek's favor in...
High quality - fair price, a clinical research contradiction?
September 01, 2009 -- Not if you have already maximised the cost effectiveness of your clinical research, maintained good quality and shortened your time to market. Or, if you don't mind spending $1 billion plus on...
Nerites Corporation Announces Two Issued Patents
MADISON, WI - (August 27, 2009) -- Nerites Corporation announced Thursday that the United States Patent and Trademark Office (USPTO) issued two new patents covering the company's technology. These "composition of...
ETHICON ENDO-SURGERY ANNOUNCES AGREEMENT WITH HOLOGIC, INC. TO RESOLVE PATENT DISPUTES
CINCINNATI- February 19, 2009 - Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, announced today that it has reached an agreement with Hologic, Inc., and Hologic subsidiary Suros Surgical Systems, Inc., settling...
EPEIUS BIOTECHNOLOGIES AWARDED PATENTS IN EUROPE FOR TARGETED GENETIC ANTI-CANCER MEDICINE: COMPANY EXPANDS IMPRESSIVE INTELLECTUAL PROPERTY ESTATE
San Marino, Calif. - December 16, 2008 - Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and...
© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
